HomeInsightsResults

Norris Medicines Ltd Quarterly Result

Norris Medicines Ltd Quarterly Result

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

1.3 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 25, 2024

Image

Norris Medicines Ltd

NSE: NORRISMEDICINES

Net Profit

₹ -0.36

Last updated on: Nov 25, 2024

Key Highlights

  • The revenue of Norris Medicines Ltd for the Sep '24 is ₹ 1.27 crore as compare to the Jun '24 revenue of ₹ 0.74 crore. This represent the growth of 71.62161%.
  • The ebitda of Norris Medicines Ltd for the Sep '24 is ₹ -0.14 crore as compare to the Jun '24 ebitda of ₹ -0.15 crore. This represent the decline of -6.6666694%.
  • The net profit of Norris Medicines Ltd for the Sep '24 is ₹ -0.36 crore as compare to the Jun '24 net profit of ₹ -0.37 crore. This represent the decline of -2.7027001%.

Results Analysis

Market Price of Norris Medicines Ltd

1M

1Y

3Y

5Y

Monitoring Norris Medicines Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202420.46
21 Nov 202421.53
19 Nov 202422.66
18 Nov 202423.85
14 Nov 202425.1
13 Nov 202426.42
12 Nov 202425.17
11 Nov 202423.98
08 Nov 202422.84
07 Nov 202421.76

Historical Revenue of Norris Medicines Ltd

No data available

* All values are in crore

Historical EBITDA of Norris Medicines Ltd

No data available

* All values are in crore

Historical Net Profit of Norris Medicines Ltd

No data available

* All values are in crore

Norris Medicines Ltd News Hub

News

Norris Medicines to table results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 Novemb...

Read more

12 Nov 202411:24

News

Norris Medicines to conduct AGM

Norris Medicines announced that the 33th Annual General Meeting (AGM) of the company will ...

Read more

16 Sep 202413:58

News

Norris Medicines to discuss results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 August...

Read more

09 Aug 202416:52

News

Norris Medicines to discuss results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 29 May 20...

Read more

25 May 202419:21

News

Norris Medicines schedules board meeting

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 Februa...

Read more

09 Feb 202412:37

News

Norris Medicines to convene EGM

Norris Medicines announced that an Extra Ordinary General Meeting (EGM) of the Company wil...

Read more

01 Jan 202410:29

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Norris Medicines Ltd Quarterly Result

What is the EPS of Norris Medicines Ltd stock?

The Earnings Per Share (EPS) of Norris Medicines Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Norris Medicines Ltd EPS calculated?

The EPS of Norris Medicines Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Norris Medicines Ltd report its EPS?

Norris Medicines Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Norris Medicines Ltd EPS?

Factors that influence the EPS of Norris Medicines Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Norris Medicines Ltd EPS growth indicate future performance?

Yes, consistent growth in Norris Medicines Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*